205 related articles for article (PubMed ID: 32515651)
21. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
Okour M; Al-Kofahi M; Austin D
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
[No Abstract] [Full Text] [Related]
22. Imported COVID-19 cases pose new challenges for China.
Chen L; Cai J; Lin Q; Xiang B; Ren T
J Infect; 2020 Jun; 80(6):e43-e44. PubMed ID: 32283157
[No Abstract] [Full Text] [Related]
23. The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19.
Wang H; Song J; Pan L; Yao Y; Deng YK; Wang ZC; Liao B; Ma J; He C; Zeng M; Liu Z
J Allergy Clin Immunol Pract; 2020; 8(10):3597-3599.e2. PubMed ID: 32980581
[No Abstract] [Full Text] [Related]
24. Leukotrienes, a potential target for Covid-19.
Citron F; Perelli L; Deem AK; Genovese G; Viale A
Prostaglandins Leukot Essent Fatty Acids; 2020 Oct; 161():102174. PubMed ID: 32977289
[No Abstract] [Full Text] [Related]
25. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
26. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
[No Abstract] [Full Text] [Related]
27. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.
Monneret G; de Marignan D; Coudereau R; Bernet C; Ader F; Frobert E; Gossez M; Viel S; Venet F; Wallet F
Cell Mol Immunol; 2020 Sep; 17(9):1001-1003. PubMed ID: 32728202
[No Abstract] [Full Text] [Related]
28. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
[No Abstract] [Full Text] [Related]
29. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
[TBL] [Abstract][Full Text] [Related]
30. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
31. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
32. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
Goudsmit J
Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
[No Abstract] [Full Text] [Related]
33. Immunomodulation in COVID-19.
Ingraham NE; Lotfi-Emran S; Thielen BK; Techar K; Morris RS; Holtan SG; Dudley RA; Tignanelli CJ
Lancet Respir Med; 2020 Jun; 8(6):544-546. PubMed ID: 32380023
[No Abstract] [Full Text] [Related]
34. Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
Molina-Iturritza E; San-José-Muñiz I; Ganchegui-Aguirre M; Balerdi-Sarasola L; Ortiz-de-Zárate-Ibarra Z; Gainzarain-Arana JC; Portu-Zapirain J
AIDS; 2020 Sep; 34(11):1696-1697. PubMed ID: 32769770
[No Abstract] [Full Text] [Related]
35. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
36. Will helminth co-infection modulate COVID-19 severity in endemic regions?
Bradbury RS; Piedrafita D; Greenhill A; Mahanty S
Nat Rev Immunol; 2020 Jun; 20(6):342. PubMed ID: 32358579
[TBL] [Abstract][Full Text] [Related]
37. Is COVID-19 more severe in older men?
Liang X
Postgrad Med J; 2020 Jul; 96(1137):426. PubMed ID: 32404490
[No Abstract] [Full Text] [Related]
38. Introduction: Finding a way in daily clinical practice during COVID-19 pandemic.
Twickler TB; Regieli JJ
Eur J Clin Invest; 2020 Jul; 50(7):e13329. PubMed ID: 32573773
[No Abstract] [Full Text] [Related]
39. The Wuhan SARS-CoV-2-What's next for China.
Lu H; Stratton CW; Tang YW
J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
[No Abstract] [Full Text] [Related]
40. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]